Back to contributors

Author

Dr. Meng Zhao

Editorial Lead, NIH Grant Explorer

About

Meng Zhao oversees long-form editorial coverage on NIH grant strategy, study section behavior, and mechanism selection at NIH Grant Explorer. Her work focuses on translating raw NIH RePORTER data and publicly available federal records into practical guidance for first-time R01 applicants, postdocs preparing K-series transitions, and trainees navigating F-series fellowships.

Areas of focus

  • NIH grant application strategy
  • Specific Aims and Research Strategy review
  • K99/R00 and F-series fellowship guidance
  • NIH study section interpretation
  • Funding-trend analysis and institute fit

Recent guides

Funding Strategy9 min read

DOE SBIR/STTR for Academic Researchers: Topics, Award Sizes and How to Apply

What academic and biomedical researchers should know about DOE SBIR/STTR: Fall 2026 Phase I topics, the December 16 pitch date, inconsistent award-size reports, and how DOE compares with NIH.

Nov 4, 2026Read
Funding Strategy9 min read

NIH R21 Budget: The $275K Cap, Modular Budgets and What to Request

How the NIH R21 budget limit works: the $275,000 two-year direct cost cap, the $200,000 per-year ceiling, modular budget mechanics, and how to decide what to request.

Nov 3, 2026Read
Grant Application Guide8 min read

eRA Commons Username: How to Find, Create or Recover Yours

What your eRA Commons username is, where to find it, who creates the account, how to recover a forgotten username, and what to check when it does not match your NIH application.

Nov 2, 2026Read
Grant Writing Tips9 min read

How Long Should Your NIH R01 Be? Choosing a 3, 4, or 5-Year Project Period

How to choose an NIH R01 project period of three, four, or five years: how scope, budget caps, staffing, and renewal timing should drive the number, and what reviewers read into your timeline.

Nov 1, 2026Read
Grant Writing Tips9 min read

Sex as a Biological Variable in NIH Grants: How to Write the SABV Plan Reviewers Accept

How to address sex as a biological variable (SABV) in an NIH application: what the policy asks for, where it belongs in the Research Strategy, how to justify single-sex designs, and the mistakes that draw rigor critiques.

Oct 31, 2026Read
Grant Writing Tips9 min read

Overly Ambitious NIH Grant? How to Scope an R01 So Reviewers Believe It

Why reviewers write "overly ambitious" in NIH summary statements, how to audit your R01 scope, and how to cut, sequence, and de-risk aims without losing impact.

Oct 30, 2026Read
Funding Strategy9 min read

Submit or Wait? A Go/No-Go Checklist for the February 2027 NIH R01 Deadline

A practical go/no-go framework for deciding whether to submit an NIH R01 in the February 2027 cycle or wait for June, with six readiness signals and red flags.

Oct 29, 2026Read
Funding Strategy8 min read

NSF SBIR Deadlines 2026-2027: Phase I Dates and the Project Pitch Step

What is reported about NSF SBIR/STTR Phase I deadlines for 2026-2027, how the Project Pitch gate works, where sources disagree, and how to choose between NSF and NIH small business funding.

Oct 28, 2026Read